We describe a gas-chromatographic procedure forthe simultaneousdeterminationof amitriptyline and its active within-day and 8.6% and 3.4% day-to-day foramitriptyline and nortriptyline, respectively. The procedure was applied to patients receiving therapeutic doses of both drugs and also to patients who had taken overdoses of amitriptyline.
a commercially available therapeutic agent ("Aventyl," Eli Lilly and Co.), are among the most widely administered tnicyclic antidepressants ( Figure 1 ). There have been reports of large individual differences in steadystate concentrations in the plasma of patients receiving the same therapeutic doses of these tricyclics, and monitoring these compounds in plasma has become of interest in the treatment of depression (1) (2) (3) (4) . Concentrations of amitniptyline and nortriptyline in plasma after therapeutic doses range from 20 to 300 ag/liter (5), and, for nortriptyline, intermediate concentrations (50-140 sg/liter) may provide better clinical response than either lower or higher concentrations (6). While mass fragmentography, with its superior sensitivity and specificity, is ideally suited for the determination of these drugs at such low concentrations (7), it is not widely available.
Gas-liquid chromatography has been used to measure amitniptyline and nortriptyline (5, [8] [9] [10] [11] ; however, in most of these procedures conventional flame-ionization gas chromatography is used, and the lower limit of detection has been at best 20 ag/liter, and involves a rather laborious extraction and derivatization (5). Borgaand Garle (8) reported an electron-capturegas-chromatographic procedure that is sensitive to 10 ag/liter, but it was described only for nortriptyline and also requires an involved extraction and derivatization with heptafluorobutynic anhydride. Wallace et al. (11) recently reported another electroncapture gas-chromatographic assay sensitive to 5 hg! liter, but their method requires prior oxidation of both amitriptyline and nortriptyline to the same compound (anthraquinone), so that only a value for total tricyclics is obtained.
Here, we report a relatively simple gas-chromatographic procedure for the simultaneous, direct determination of undenivatized amitriptyline and nortriptyline in human plasma at concentrations as low as 5 tgIliter, with use of a selective nitrogen ("alkali flame") detector. Karmen and Guiffrida (12) originally described this type of detector. For each run, appropriately dilute the concentrated standard with drug-free plasma to achieve the desired concentrations (usually 10-300 Mg/liter).
Materials and Methods

Apparatus
Procedure
All glassware was washed with HC1 (1 mol/liter) and rinsed with hexane/isoamyl alcohol before use. Blood from patients receiving therapeutic doses of amitriptyline or nortriptyline was sampled into heparinized glass syringes.
Blood from patients who had taken overdoses of amitriptyline was collected into evacuated glass tubes containing no anticoagulant (Vacutainers; Becton-Dickinson, Division of Becton, Dickinson and Co., Rutherford, N. J. 07070). If they were not to be analyzed promptly, the samples were centrifuged and the plasma ( or serum) frozen (-15 #{176}C).
Place 3 ml of plasma (samples, drug-free plasma, and plasma standards) into 15-ml glass tubes equipped with Teflon-lined screw caps. Adjust the pH to 10.5 by adding 0.5 ml of saturated Na2CO3. Add 10 ml of hexane! isoamyl alcohol containing the internal standard and extract for 3 mm. Centrifuge at 3000 rpm for 3 mm and transfer the upper solvent layer to a clean 15-ml screw-capped tube. Add 1 ml of HC1 (0.1 mol/liter), extract for 3 mm, and, after. centrifugation, aspirate and discard the upper solvent phase. Wash the acid for 1 mm with 2 ml of hexane/isoamyl alcohol (without internal standard), centrifuge, and discard the upper solvent layer. Add 1 scoopful (about 500 mg) of anhydrous Na2CO3 to saturate the aqueous phase, mix well, and extract for 3 mm with 2 ml of hexane/isoamyl alcohol (without internal standard). After centrifugation, dehydrate the upper solvent layer over anhydrous Na2SO4 in a 10-rnl test tube. Transfer the solvent to a 5-ml glass centrifuge tube and evaporate it in a stream of nitrogen at room temperature.
Dissolve the residue in 20 M1 of methanol and chromatograph 4 Ml under the following conditions: column temperature, 235 #{176}C (isothermal); injector temperature, 255 #{176}C; nitrogen detector temperature, 300 #{176}C (detector current setting of 5.9-6.9, corresponding to rubidium glass bead temperatures of about 350-400 #{176}C); carrier gas (helium) flow rate, 20 mi/mm; air flow, 400 ml/min; hydrogen, 1 ml/min; and amplifier setting, Xl. Calculate the peak-area ratio (amitriptyline or nortriptyline/ protriptyline internal standard) for each sample and determine the plasma concentration by comparison to the peak-area ratios of the extracted standards.
Results
We analyzed 24 different drug-free plasmas, and 16 gave slight responses corresponding in retention time to amitriptyline and nortriptyline, equivalent to 3 pg/literor lessof both. The detection limit for each drug was thus considered to be about 5 g!liter for the proposed method. The relationship between relative peak area and plasma concentration of amitriptyline and nortriptyline was linear over the range 5 to 300 Mg/liter (r = 0.99). Nonlinearity was observed at concentrations exceeding 300 hg/liter, and samples were diluted and re-analyzed if above this concentration.
For precision studies, drug-free plasma was supplemented to a concentration of 200 tg each of amitriptyline and nortriptyline per liter. Twelve aliquots of this plasma were analyzed in one day to determine withinday precision and the remaining plasma was frozen (-15 #{176}C). One aliquot of the frozen supplemented plasma was thawed and analyzed on 11 different days during 30 days, to determine day-to-day precision and sample stability.
The coefficients of variation were 4.6% and 4.3% within-day and 8.6% and 3.4% day-to-day for amitriptyline and nortriptyline, respectively. The analytical recovery was 45-50% for both amitriptyline and nortriptyline, determined by comparison of relative peak areas of extracted supplemented plasmas with those of nonextracted methanolic standards. This incomplete recovery is corrected for by the use of extractedplasma standards in the proposed procedure.
The stability of the drugs in plasma was established to be at leastone month when frozen at -15 #{176}C. The extract residues were stable at least overnight when stored at 4 #{176}C in a desiccator.
When plasma was collected in heparinized glass syringes, essentially "clean" chromatograms were obtained, the background response being equivalent to 3 pg/liter or less for amitriptyline and nortriptyline. In addition, a small noninterfering peak at retention time 1.14 relative to the internal standard was usually seen (peak d, Figure 2 ). This peak was much more pronounced in specimens that had been collected in Vacutainers.
Forty-seven commonly used basic drugs (Table 1) were screened for interference in the assay by comparing the relative retention time of their nonextracted methanolic solutions with those of amitriptyline (0.74) and nortriptyline (0.86) under the chromatographic conditions of the assay. (Acidic drugs, such as barbiturates, would not be recovered under the alkaline extraction conditions of the assay.) Doxepin ("Smnequan," Pfizer) had a relative retention time identical to that of nortriptyline, and, when drug-free plasma was supplemented with doxepin, it extracted and chromatographed as nortriptyline.
Desipramine, the active Ndesmethyl metabolite of imipramine ("Tofranil," Geigy), and itself a commercially available antide- We analyzed 12 plasmas from nine patients in whom therapeutic doses of amitriptyline and (or) nortriptyline had been stabilized (Table 2 ). In addition, we analyzed 25 samples from 17 patients, each of whom had ingested a nonfatal overdose of medications including amitriptyline.
Plasma drug values in overdose ranged up to 1080 Mg/liter for amitriptyline, up to 337 ag/liter for nortriptyline, and up to 1260 Mg/liter for total tricyclics (sum of both). Data on three overdoses involving amitriptyline alone without other drugs are also shown in Table 2 .
To validate the procedure further, we determined four consecutive values for amitriptyline and nortriptyline in one patient who had taken an overdose of amitriptyline, and drew decay curves for amitriptyline, nortriptyline, and total tricyclics (the sum of both). All three semilog curves were linear ( Figure 3 ).
Discussion
The interest in optimizing drug therapy by monitoring concentrations in blood is increasing, and this is true for the tricyclic antidepressants as well. Values for our series of patients, stabilized on therapeutic doses (Table 2) , were similar to those obtained by others (1-3, 5, 6, 9, 13, 14) , and they displayed moderate individual variation,as has also been previously reported (1) (2) (3) (4) . As expected, both amitriptyline and its desmethyl metabolite nortriptyline were found in the plasmas of patients receiving amitriptyline, but only nortriptyline in patients receiving nortriptyline.
Some of our patients were on lower initial doses (50 mg) than in the other reported studies (1-3, 6, 9, 13, 14) so that initial values were occasionally lower in our series. As doses were increased, the concentrations in plasma also increased. Values for amitriptyline after acute amitriptyline overdose were usually greater than those for nortriptyline, probably reflecting insufficient time for mono-N-demethylation of the parent drug. Except for three patients, all of our overdose cases had consumed other drugs in addition to amitriptyline, and so we do not now have sufficient data to make adequate clinical correlations.
Fatalities have been frequent in other reports of amitriptyline overdose (10, 15-18); all our patients survived.
Because concentrations of amitriptyline and nortriptyline in plasma after therapeutic doses are low, conventional flame-ionization gas chromatography at best affords marginal sensitivity, and derivatization is required to enhance the response. These low values, however, are well within the range of measurement achieved by gas chromatography with a selective nitrogen detector, and derivatization is not required. Because protriptyline is both an isomer of nortriptyline and a structural homoiog of amitriptyline (Figure 1 ), has about the same solubility properties that they have, and is itself only a rarely administered tncyclic antidepressant, we selected it as the internal standard for the assay. Ithas been used as an internal CLINICAL CHEMISTRY, Vol. 22. No. 6, 1976 781 standard by others in the assay of amitriptyline and nortriptyline (9, 16). Back-extraction of amitniptyline and nortniptyline into dilute HC1 provides sufficiently "clean" extracts, free from neutral lipids, and has been used by others (9).
Our day-to-day use of the nitrogen detector has been described previously (19). We did not study the more polar lO-hydroxyamitniptyline and 10-hydroxynortriptyline metabolites.
However, it is unlikely that they would be extracted under the conditions of the proposed method.
Of 47 common basic drugs, only doxepin and desipramine interfered.
Doxepin and desipramine, however, themselves tricyclic compounds, would not be administered with amitriptyline or nortriptyline, although hypothetically they could be combined in an overdose situation.
We specifically analyzed plasma from patients receiving therapeutic doses of chiorpromazine, perphenazine, thioridazine, and benztropine (all included in No interferences were found. The noninterfering contaminant peak at relative retention time 1.14 (peak d, Figure 2 ) was considerably enhanced in specimens drawn into Vacutainers.
It may represent tri(2-butoxyethyl)phosphate, which has been identified by others (20). When blood was collected into heparinized glass syringes, as was the case for all our patients on therapeutic doses of the tricyclics, this peak was small. 
